Comparing Abraxane vs Taxotere
| Abraxane (paclitaxel protein-bound) | Taxotere (docetaxel) |
|
|---|
| Abraxane (paclitaxel protein-bound) | Taxotere (docetaxel) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Non Small Cell Lung Cancer, Pancreatic Cancer, Breast Cancer - Metastatic, Breast Cancer. Abraxane may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Prostate Cancer, Breast Cancer, Gastric Cancer, Breast Cancer - Metastatic, Non Small Cell Lung Cancer, Head and Neck Cancer. Taxotere may also be used for purposes not listed in this... View more |
||||||||
| More about Abraxane (paclitaxel protein-bound) | More about Taxotere (docetaxel) | ||||||||
| Ratings & Reviews | |||||||||
|
Abraxane has an average rating of 6.7 out of 10 from a total of 6 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 33% reported a negative effect. |
Taxotere has an average rating of 5.2 out of 10 from a total of 11 ratings on Drugs.com. 36% of reviewers reported a positive effect, while 45% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
|
View all Abraxane side effects |
View all Taxotere side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
|||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
View all Abraxane prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | |||||||||
|
|
||||||||
| Brand Names | |||||||||
|
N/A |
Other docetaxel brands include: Docivyx | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
27 hours |
11.1 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 523 drugs are known to interact with Abraxane:
|
A total of 520 drugs are known to interact with Taxotere:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
|
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
N/A |
May 14, 1996 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
|
N/A |
|||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Verzenio
Verzenio is used to treat early and advanced-stage hormone receptor-positive, HER2-negative breast ...
Rybrevant
Rybrevant is used to treat advanced non-small cell lung cancer (NSCLC) in adults that has certain ...
Kisqali
Kisqali (ribociclib) is used to treat a certain type of advanced metastatic breast cancer. Includes ...
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Methotrexate
Methotrexate is used to treat certain types of cancer of the breast, skin, head and neck, or lung ...
Avastin
Avastin is used to brain tumors and cancers of the kidney, colon, rectum, or lung. Learn about side ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.